Brief: Bio-Rad Q3 EBIT Margin -7.6%
04/11/2026 21:16
BRIEF-Bio-Rad Q3 EBIT Margin -7.6% Nov 04 (Reuters) - Bio-Rad Q3 net income USD 458.6 million.
- Q3 EPS USD 17.02
- Q3 sales USD 656.4 million
- Q3 gross margin 50.1%
Recent news on Bio-Rad Laboratories
See all newsUS RESEARCH ROUNDUP-Cencora, Dave, Uber
Bio-Rad Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Bio-Rad's Q3 revenue comes slightly above estimates on Clinical Diagnostics growth
Brief: Bio-Rad Q3 EBIT Margin -7.6%
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary